A recent investigation by the watchdog group Do No Harm has revealed that the National Cancer Institute (NCI) is actively allocating millions of dollars in grant funding to enhance diversity, equity, and inclusion (DEI) in the field of medicine. The report indicates that approximately $218 million in NCI grants are being directed towards supporting underrepresented groups, primarily racial minorities, to increase their presence in the cancer workforce.
Before President Donald Trump's administration, during the Biden era, around 3% of the NCI's annual grant funding was designated for institutions to hire more minority faculty members and scientists. This move has been criticized by some, including Republicans, who argue for a focus on meritocracy over DEI initiatives.
